Ad is loading...
AMADX
Price
$38.89
Change
+$0.42 (+1.09%)
Updated
Nov 22 closing price
VVIAX
Price
$70.26
Change
+$0.54 (+0.77%)
Updated
Nov 22 closing price
Ad is loading...

AMADX vs VVIAX

Header iconAMADX vs VVIAX Comparison
Open Charts AMADX vs VVIAXBanner chart's image
American Century Discplnd Cor Val A
Price$38.89
Change+$0.42 (+1.09%)
VolumeN/A
CapitalizationN/A
Vanguard Value Index Adm
Price$70.26
Change+$0.54 (+0.77%)
VolumeN/A
CapitalizationN/A
AMADX vs VVIAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
AMADX vs. VVIAX commentary
Nov 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMADX is a StrongBuy and VVIAX is a StrongBuy.

FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 184B vs. AMADX (2.09B). VVIAX pays higher dividends than AMADX: VVIAX (2.36) vs AMADX (1.18). AMADX was incepted earlier than VVIAX: AMADX (27 years) vs VVIAX (24 years). AMADX is a more actively managed with annual turnover of: 179.00 vs. VVIAX (10.00). AMADX has a lower initial minimum investment than VVIAX: AMADX (2500) vs VVIAX (3000). AMADX (26.36) and VVIAX (26.09) have marching annual gain over last year. VVIAX return over 5 years is better than : 53.09 vs. AMADX (6.89).
AMADXVVIAXAMADX / VVIAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence27 years24 years-
Gain YTD18.81919.67296%
Front LoadN/AN/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets2.09B184B1%
Annual Yield % from dividends1.182.3650%
Returns for 1 year26.3626.09101%
Returns for 3 years-10.9624.77-44%
Returns for 5 years6.8953.0913%
Returns for 10 years10.48112.269%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DOLE15.260.19
+1.26%
Dole plc
NCNO40.450.37
+0.92%
nCino
SGHT3.760.03
+0.80%
Sight Sciences
VICI32.370.25
+0.78%
VICI Properties
SABS3.070.01
+0.33%
SAB Biotherapeutics